• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.70% Nasdaq Up1.66%

    Bovie Medical Corporation (BVX)

    3.37 Down 0.13(3.71%) 2:26PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Bovie Medical Corporation
    5115 Ulmerton Road
    Clearwater, NY 33760
    United States - Map
    Phone: 727-384-2323
    Fax: 727-347-9144
    Website: http://www.boviemedical.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:136

    Business Summary 

    Bovie Medical Corporation, an energy-based medical device company, develops, manufactures, and markets a range of electrosurgical products and technologies, and related medical products worldwide. The company’s electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers battery operated cauteries; and battery operated medical lights for use in ophthalmology, as well as for general surgery, hip replacement surgery, and the placement of endotracheal tubes in emergency and surgical procedures. In addition, the company manufactures physicians’ office use penlights; and a nerve locator stimulator used for identifying motor nerves in hand and facial reconstructive surgery. Further, Bovie Medical Corporation is developing Derm 101 and Derm 102 products, which are 10 watt high frequency desiccators for use in family practice, aesthetics, and dermatology settings; and Seal-N-Cut, a disposable endoscopic surgical handle. The company markets its products through medical distributors to hospitals, doctor’s offices, and other healthcare facilities. Bovie Medical Corporation was founded in 1982 and is based in Clearwater, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Bovie Medical Corporation

    Key Executives 
    Mr. Andrew Makrides Esq., 72
    Exec. Chairman
    Mr. Robert L. Gershon , 47
    Chief Exec. Officer and Director
    Mr. J. Robert Saron , 61
    Pres, Chief Sales & Marketing Officer and Director
    Mr. Moshe Citronowicz , 61
    Sr. VP
    Mr. Peter L. Donato , 44
    Chief Financial Officer, Exec. VP, Sec. and Treasurer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders